Impact of Tumor Localization and Method of Preoperative Biopsy on Sentinel Lymph Node Mapping After Periareolar Nuclide Injection

Background To evaluate whether tumor localization and method of preoperative biopsy affect sentinel lymph node (SLN) detection after periareolar nuclide injection in breast cancer patients. Methods and Findings 767 breast cancer patients were retrospectively included. For lymphscintigraphy periareolar nuclide injection was performed and the SLN was located by gamma camera. Patient and tumor characteristics were correlated to the success rate of SLN mapping. SLN marking failed in 9/61 (14.7%) patients with prior vacuum-assisted biopsy and 80/706 (11.3%) patients with prior core needle biopsy. Individually evaluated, biopsy method (p = 0.4) and tumor localization (p = 0.9) did not significantly affect the SLN detection rate. Patients with a vacuum-assisted biopsy of a tumor in the upper outer quadrant had a higher odds ratio of failing in SLN mapping (OR 3.8, p = 0.09) compared to core needle biopsy in the same localization (OR 0.9, p = 0.5). Conclusions Tumor localization and preoperative biopsy method do not significantly impact SLN mapping with periareolar nuclide injection. However, the failure risk tends to rise if vacuum-assisted biopsy of a tumor in the upper outer quadrant is performed.

[1]  A. Giuliano,et al.  Neoadjuvant Chemotherapy and Surgical Management of the Axilla in Breast Cancer: A Review of Current Data. , 2015, Oncology.

[2]  Barbara L. Smith,et al.  To do or not to do: axillary nodal evaluation after ACOSOG Z0011 Trial. , 2014, Radiographics : a review publication of the Radiological Society of North America, Inc.

[3]  H. Kuerer,et al.  Management of axillary disease. , 2014, Surgical oncology clinics of North America.

[4]  M. Latteri,et al.  Lymphoscintigraphy with peritumoral injection versus lymphoscintigraphy with subdermal periareolar injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients , 2014, Acta radiologica.

[5]  E. Kubista,et al.  Factors influencing the identification rate of the sentinel node in breast cancer. , 2011, European journal of cancer care.

[6]  M. Ross,et al.  Sentinel lymph node dissection is technically feasible in older breast cancer patients. , 2010, Clinical breast cancer.

[7]  U. S. Kristoffersen,et al.  Factors influencing sentinel lymph node identification failure in breast cancer surgery. , 2008, Breast.

[8]  O. Nieweg,et al.  Excision biopsy of breast lesions changes the pattern of lymphatic drainage , 2007, The British journal of surgery.

[9]  P. Schlag,et al.  Impact of Patient- and Disease-Specific Factors on SLNB in Breast Cancer Patients. Are Current Guidelines Justified? , 2007, World Journal of Surgery.

[10]  E. Heuts,et al.  Results of sentinel node biopsy not affected by previous excisional biopsy. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[11]  R. Newcombe,et al.  Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer – results of the ALMANAC validation phase , 2006, Breast Cancer Research and Treatment.

[12]  K. McMasters,et al.  Biopsy type does not influence sentinel lymph node status. , 2005, American journal of surgery.

[13]  Todd M Tuttle,et al.  Factors predicting failure to identify a sentinel lymph node in breast cancer. , 2005, Surgery.

[14]  D. Bentrem,et al.  Failure of sentinel lymph node mapping in patients with breast cancer. , 2004, Journal of the American College of Surgeons.

[15]  E. Rutgers,et al.  Lymphatic Drainage Patterns From the Breast , 2004, Annals of surgery.

[16]  F. Ferrarese,et al.  Subareolar Injection May Be More Accurate Than Other Techniques for Sentinel Lymph Node Biopsy in Breast Cancer , 2003, Annals of Surgical Oncology.

[17]  L. Krogerus,et al.  The effect of patient and tumour characteristics on visualization of sentinel nodes after a single intratumoural injection of Tc 99m labelled human albumin colloid in breast cancer. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[18]  S. Noguchi,et al.  Patient age affects identification rate of sentinel nodes in breast cancer. , 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[19]  K. Kern,et al.  Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid. , 2002, Journal of the American College of Surgeons.

[20]  P. Laud,et al.  Does breast tumor location influence success of sentinel lymph node biopsy? , 2002, Journal of the American College of Surgeons.

[21]  F. Su,et al.  [Clinical and histological factors associated with sentinel node identification in breast cancer]. , 2002, Zhonghua wai ke za zhi [Chinese journal of surgery].

[22]  P. Schrenk,et al.  Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer , 2001, The Lancet.

[23]  A. Giuliano,et al.  Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  C. Redmond,et al.  Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update , 1983, Cancer.

[25]  U. Chetty,et al.  Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. , 2005, European journal of cancer.

[26]  R. Kimble,et al.  The Australian and New Zealand Journal of Surgery , 2002 .